BMI with tail |
16.42 |
36 |
27 |
158.8 |
0.98 |
4.75e-102 |
Adcy3
Ncoa1
Kif16b
Snrpb2
Pcsk2
Dstn
Rrbp1
Kat14
Dzank1
Rbbp9
Sec23b
Dtd1
Pdzd8
Rab11fip2
Fam204a
Prlhr
Cacul1
Dennd10
Prdx3
Grk5
Efr3b
Nanos1
Zfp133
Mgme1
Otor
Zfp950
Ces2c
Sfxn4
Smim26
Itsn2
Casp7
ENSRNOG00000065260
ENSRNOG00000065957
ENSRNOG00000066171
ENSRNOG00000067833
ENSRNOG00000068145
|
BMI without tail |
15.02 |
29 |
15 |
88.2 |
0.9 |
1.37e-47 |
Kif16b
Snrpb2
Pcsk2
Dstn
Rrbp1
Dzank1
Rbbp9
Sec23b
Dtd1
Pdzd8
Rab11fip2
Fam204a
Prlhr
Cacul1
Dennd10
Prdx3
Grk5
Nanos1
Zfp133
Mgme1
Otor
Zfp950
Ces2c
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
ENSRNOG00000065957
ENSRNOG00000067833
ENSRNOG00000068145
|
Body weight |
15.34 |
42 |
32 |
188.2 |
0.97 |
5.09e-99 |
Dnajc27
Adcy3
Ncoa1
Kif16b
Snrpb2
Klhl29
Pcsk2
Dstn
Rrbp1
Kat14
Dzank1
Rbbp9
Sec23b
Dtd1
Pdzd8
Rab11fip2
Fam204a
Prlhr
Cacul1
Dennd10
Prdx3
Grk5
Dtnb
Efr3b
Nanos1
Zfp133
Mgme1
Otor
Zfp950
Ces2c
Sfxn4
Smim26
Itsn2
Fam228b
Cenpo
Casp7
ENSRNOG00000064438
ENSRNOG00000065260
ENSRNOG00000065957
ENSRNOG00000066171
ENSRNOG00000067833
ENSRNOG00000068145
|
Epididymis fat weight |
21.47 |
43 |
34 |
200 |
0.93 |
3.14e-81 |
Dnajc27
Adcy3
Ncoa1
Kif16b
Snrpb2
Klhl29
Pcsk2
Dstn
Rrbp1
Kat14
Dzank1
Rbbp9
Sec23b
Dtd1
Pdzd8
Rab11fip2
Fam204a
Prlhr
Cacul1
Dennd10
Prdx3
Grk5
Dtnb
Efr3b
Nanos1
Zfp133
Mgme1
Otor
Zfp950
Ces2c
Sfxn4
Smim26
Itsn2
Fam228b
Cenpo
Casp7
ENSRNOG00000064438
ENSRNOG00000065260
ENSRNOG00000065957
ENSRNOG00000066171
ENSRNOG00000067833
ENSRNOG00000068145
Ubxn2a
|
Glucose |
9.9 |
5 |
0 |
0 |
0.99 |
4.87e-10 |
Cacul1
Dennd10
Zfp950
Ces2c
Sfxn4
|
Heart weight |
10.73 |
11 |
0 |
0 |
1 |
6.38e-24 |
Rab11fip2
Cacul1
Dennd10
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
ENSRNOG00000068145
|
Left kidney weight |
12.48 |
14 |
13 |
76.5 |
0.87 |
8.38e-15 |
Rab11fip2
Prlhr
Cacul1
Dennd10
Prdx3
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
ENSRNOG00000065957
ENSRNOG00000068145
|
Right kidney weight |
12.46 |
14 |
13 |
76.5 |
0.86 |
5.89e-14 |
Rab11fip2
Prlhr
Cacul1
Dennd10
Prdx3
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
ENSRNOG00000065957
ENSRNOG00000068145
|
Tail length |
91.11 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Length with tail |
4.5 |
8 |
0 |
0 |
0.88 |
1.25e-06 |
Kif16b
Cacul1
Nanos1
Otor
Zfp950
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
|
Length without tail |
14.24 |
7 |
1 |
5.9 |
0.84 |
4.30e-05 |
Rab11fip2
Prlhr
Cacul1
Zfp950
Sfxn4
ENSRNOG00000064438
ENSRNOG00000068145
|
Liver weight, left |
10.77 |
5 |
1 |
5.9 |
0.81 |
4.20e-04 |
Rab11fip2
Prlhr
Cacul1
Sfxn4
ENSRNOG00000064438
|
Liver weight, right |
12.79 |
13 |
4 |
23.5 |
1 |
5.28e-44 |
Pdzd8
Rab11fip2
Prlhr
Cacul1
Dennd10
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
Casp7
ENSRNOG00000064438
ENSRNOG00000065260
|
Retroperitoneal fat weight |
30.08 |
43 |
42 |
247.1 |
0.98 |
1.23e-128 |
Dnajc27
Adcy3
Ncoa1
Kif16b
Snrpb2
Klhl29
Pcsk2
Dstn
Rrbp1
Kat14
Dzank1
Rbbp9
Sec23b
Dtd1
Pdzd8
Rab11fip2
Fam204a
Prlhr
Cacul1
Dennd10
Prdx3
Grk5
Dtnb
Efr3b
Nanos1
Zfp133
Mgme1
Otor
Zfp950
Ces2c
Sfxn4
Smim26
Itsn2
Fam228b
Cenpo
Casp7
ENSRNOG00000064438
ENSRNOG00000065260
ENSRNOG00000065957
ENSRNOG00000066171
ENSRNOG00000067833
ENSRNOG00000068145
Ubxn2a
|
Intraocular pressure |
29.37 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Extensor digitorum longus weight |
4.95 |
19 |
1 |
5.9 |
0.97 |
1.58e-27 |
Pitpnm3
Ube2g1
RGD1304728
Slc13a5
Fbxo39
Tekt1
Spns3
Ankfy1
Atp2a3
Camkk1
Tax1bp3
Zzef1
Cyb5d2
Sfxn4
Xaf1
Spns2
ENSRNOG00000064438
ENSRNOG00000067475
ENSRNOG00000068145
|
Soleus weight |
6.91 |
6 |
1 |
5.9 |
-0.09 |
8.11e-01 |
Ncoa1
Rab11fip2
Prdx3
Tekt1
ENSRNOG00000064438
ENSRNOG00000067475
|
Tibialis anterior weight |
6.49 |
19 |
1 |
5.9 |
0.93 |
6.65e-23 |
Pitpnm3
Ube2g1
RGD1304728
Slc13a5
Fbxo39
Tekt1
Smtnl2
Spns3
Ankfy1
Atp2a3
Camkk1
P2rx5
Tax1bp3
Zzef1
Cyb5d2
Xaf1
Spns2
ENSRNOG00000064438
ENSRNOG00000067475
|
Tibia length |
7.73 |
3 |
0 |
0 |
-0.89 |
4.14e-02 |
Kif16b
Otor
ENSRNOG00000064438
|
Number of licking bursts |
242.45 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Food consumed during 24 hour testing period |
17.5 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Times rat made contact with spout |
50.36 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Mean time between licks in bursts |
90.53 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Mean num. licks in bursts |
258.22 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Std. dev. time between licks in bursts |
291.02 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Water consumed over 24 hours |
15.6 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Indifference point 0 sec |
21.27 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Indifference point AUC |
66.71 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Delay discounting total patch changes 0 sec |
10.63 |
4 |
1 |
5.9 |
0.59 |
1.64e-01 |
Cacul1
Grk5
ENSRNOG00000064438
ENSRNOG00000068145
|
Delay discounting total patch changes 12 sec |
85.69 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Delay discounting total patch changes 18 sec |
147.01 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Delay discounting total patch changes 24 sec |
43.71 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Delay discounting total patch changes 6 sec |
44.3 |
3 |
1 |
5.9 |
-0.55 |
4.50e-01 |
Epha6
ENSRNOG00000064438
ENSRNOG00000068145
|
Delay discounting water rate 0 sec |
11.76 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Delay discounting water rate 12 sec |
44.18 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Delay discounting water rate 18 sec |
11.6 |
8 |
0 |
0 |
-0.81 |
7.19e-04 |
Kat14
Dzank1
Rbbp9
Sec23b
Dtd1
Epha6
Smim26
ENSRNOG00000064438
|
Delay discounting water rate 24 sec |
100.9 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Delay discounting water rate 6 sec |
70.2 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotor testing distance |
11.47 |
2 |
0 |
0 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Locomotor testing rearing |
23.89 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Light reinforcement 1 |
84.13 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Reaction time num false alarms |
90.08 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Reaction time num false alarms AUC |
128.16 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Reaction time trials on left |
10.33 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Reaction time mean |
62.45 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Reaction time mean AUC |
89.09 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Median of all reaction times |
80.24 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Reaction time false alarm rate |
104.16 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Reaction time premature initiation rate |
47.3 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Reaction time premature initiations |
49.75 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Std. dev. reaction times |
26.97 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Reaction time trials completed |
10.33 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Reaction time trials AUC |
15.57 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Social responses |
108.62 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Conditioned locomotion |
14.73 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Cocaine response after cond. corrected |
135.65 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Cocaine response after cond. not corrected |
176.6 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Cocaine response before conditioning |
28.56 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Saline control response |
50.64 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Condit. Reinf. active minus inactive responses |
46.4 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Condit. Reinf. active-inactive response ratio |
68.68 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Condit. Reinf. active responses |
11.07 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Condit. Reinf. inactive responses |
20.59 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. lever latency |
60.53 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. magazine entry latency |
173.36 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. change in total contacts |
216.69 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. index score |
102.16 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. latency score |
110.33 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. lever contacts |
29.45 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. magazine entry number |
244.87 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. intertrial magazine entries |
106.17 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. lever-magazine prob. diff. |
90.64 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. response bias |
51.3 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Conditioned reinforcement - actives |
20.28 |
2 |
0 |
0 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Conditioned reinforcement - inactives |
27.02 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
|
Intermittent access intake day 1-15 change |
103.99 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Intermittent access intake escalation |
141.1 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Intermittent access intake escalation 2 |
42.55 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Intermitt. access day 1 inactive lever presses |
30.61 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Intermittent access day 1 total infusions |
52.87 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Intermittent access day 15 total infusions |
13.65 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Intermittent access terminal intake (last 3 days) |
19.39 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Intermittent access total infusions |
17.65 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Intermittent access day 1 locomotion |
27.14 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Cocaine induced anxiety |
15.39 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Post-drug Anxiety |
20.58 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Baseline Anxiety |
18.76 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Lifetime Intake |
31.57 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
|
Progressive ratio test 1 active lever presses |
25.44 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
|
Progressive ratio test 1 breakpoint |
30.13 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
|
Progressive ratio test 2 active lever presses |
31.2 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
|
Progressive ratio test 2 breakpoint |
36.57 |
2 |
2 |
11.8 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Progressive ratio test 2 inactive lever presses |
29.3 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
|
Total sessions with >9 infusions |
15.73 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Short access day 1 total infusions |
37.11 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
|
Short access day 10 total infusions |
24.04 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Short access total infusions |
40.36 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
|
Short access day 1 locomotion |
17.24 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Compulsive drug intake |
45.38 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
One hour access (0.3 mA shock) |
33.5 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
|
One hour access (shock baseline) |
19.56 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Context. condit. distance diff. score |
240.19 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotion velocity, session 1 |
190.79 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotion distance, session 1 |
310.53 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Locomotion velocity, session 2 |
139.57 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotion distance, session 2 |
639.82 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Kif16b
ENSRNOG00000064438
|
Locomotion velocity, session 3 |
178.89 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotion distance, session 3 |
117.54 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Stereotopy head waving duration, day 3 |
33.17 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotion velocity, session 7 |
98.87 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotion distance, session 7 |
18.79 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Stereotopy head waving bouts, day 7 |
68.43 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Stereotopy head waving duration, day 7 |
102.2 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotion distance, session 8 |
171.7 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Degree of sensitization distance |
198.53 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Degree of sensitization stereotypy |
37.55 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Condit. Reinf. active-inactive response ratio |
107.34 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Condit. Reinf. active responses |
20.03 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Condit. Reinf. inactive responses |
17.25 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Incentive salience index mean |
15.58 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Condit. Reinf. lever presses |
23.04 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Time in familiar zone, hab. session 1 |
16.37 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Time in novel zone, hab. session 1 |
17.41 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Total zone transitions, hab. session 1 |
673.79 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Total locomotion distance, hab. session 1 |
279.38 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotion velocity, hab. session 1 |
349.52 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Time in familiar zone, hab. session 2 |
36.23 |
2 |
2 |
11.8 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Time in novel zone, hab. session 2 |
36.27 |
2 |
2 |
11.8 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Total zone transitions, hab. session 2 |
421.23 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Total locomotion distance, hab. session 2 |
214.28 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotion velocity, hab. session 2 |
224.99 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Total zone transitions, NPP test |
376.15 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Total locomotion distance, NPP test |
269.3 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Locomotion velocity, NPP test |
317.81 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. lever latency |
19.53 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Pavlov. Cond. magazine entry latency |
52.91 |
2 |
2 |
11.8 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Pavlov. Cond. change in total contacts |
40.12 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Pavlov. Cond. index score |
33.46 |
2 |
2 |
11.8 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Pavlov. Cond. latency score |
20.46 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Pavlov. Cond. lever contacts |
19.04 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Pavlov. Cond. magazine entry number |
38.2 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Pavlov. Cond. lever-magazine prob. diff. |
44.66 |
2 |
2 |
11.8 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Pavlov. Cond. response bias |
33.86 |
2 |
2 |
11.8 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Bone: apparent density |
31.19 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone surface |
41.33 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone volume |
14.06 |
4 |
1 |
5.9 |
0.46 |
2.48e-01 |
Rab11fip2
Cacul1
Sfxn4
ENSRNOG00000064438
|
Bone: cortical apparent density |
10.75 |
2 |
0 |
0 |
-1 |
1.38e-03 |
Cacul1
Zfp950
|
Bone: cortical area |
13.7 |
13 |
0 |
0 |
1 |
1.75e-41 |
Rab11fip2
Prlhr
Cacul1
Dennd10
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
Casp7
ENSRNOG00000065260
ENSRNOG00000065957
ENSRNOG00000068145
|
Bone: cortical porosity |
188.54 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone: cortical porosity |
155.79 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone: cortical thickness |
9.61 |
11 |
0 |
0 |
0.99 |
1.39e-16 |
Rab11fip2
Cacul1
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
ENSRNOG00000065957
ENSRNOG00000068145
|
Bone: cortical thickness |
14.15 |
3 |
0 |
0 |
-0.27 |
7.33e-01 |
Prdx3
Epha6
ENSRNOG00000064438
|
Bone: cortical tissue density |
11.42 |
4 |
0 |
0 |
-1 |
4.76e-09 |
Cacul1
Nanos1
Zfp950
Sfxn4
|
Bone: elastic displacement |
28.18 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone: endosteal estimation |
18.44 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone: final force |
11.22 |
10 |
1 |
5.9 |
0.8 |
1.41e-07 |
Rab11fip2
Cacul1
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
ENSRNOG00000068145
|
Bone: final moment |
11.18 |
11 |
1 |
5.9 |
0.84 |
3.24e-09 |
Rab11fip2
Cacul1
Dennd10
Prdx3
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
|
Bone: marrow area |
15.29 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone: maximum diameter |
8.65 |
5 |
0 |
0 |
0.99 |
1.66e-11 |
Cacul1
Nanos1
Zfp950
Sfxn4
Casp7
|
Bone: maximum force |
12.32 |
8 |
1 |
5.9 |
0.72 |
7.28e-04 |
Rab11fip2
Cacul1
Grk5
Nanos1
Zfp950
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
|
Bone: maximum moment |
10.94 |
9 |
1 |
5.9 |
0.81 |
4.63e-06 |
Rab11fip2
Prlhr
Cacul1
Grk5
Nanos1
Zfp950
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
|
Bone: minimum diameter |
14.15 |
7 |
1 |
5.9 |
0.53 |
6.23e-02 |
Cacul1
Nanos1
Zfp950
Ces2c
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
|
Bone: periosteal estimation |
8.93 |
13 |
0 |
0 |
0.94 |
3.11e-19 |
Rab11fip2
Prlhr
Cacul1
Dennd10
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
Casp7
ENSRNOG00000064438
ENSRNOG00000065260
ENSRNOG00000068145
|
Bone: periosteal perimeter |
11.12 |
11 |
0 |
0 |
0.94 |
3.83e-16 |
Rab11fip2
Cacul1
Dennd10
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
Casp7
ENSRNOG00000064438
ENSRNOG00000065260
|
Bone: post-yield work |
124.34 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone: stiffness |
136.78 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone: tissue strength |
135.98 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone: trabecular number |
64.11 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Bone: trabecular thickness |
13.27 |
11 |
0 |
0 |
0.93 |
4.69e-14 |
Rab11fip2
Prlhr
Cacul1
Dennd10
Grk5
Nanos1
Zfp950
Ces2c
Sfxn4
ENSRNOG00000064438
ENSRNOG00000065260
|
Bone: trabecular tissue density |
66.58 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Delta time in open arm before/after self-admin |
40.25 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Time in closed arm before self-admin |
77.96 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Time in closed arm after self-admin |
40.16 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Time in open arm after self-admin |
31.26 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Delta time to tail flick, test, before/after SA |
20.03 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Time >=10cm from walls, locomotor time 1 |
19.54 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Time >=10cm from walls, locomotor time 2 |
27.2 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Distance moved, locomotor task time 2 |
13.12 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Weight adjusted by age |
24.99 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Seeking ratio, delayed vs. immediate footshock |
12.28 |
1 |
0 |
0 |
0 |
1.00e+00 |
Ces2c
|
Locomotion in novel chamber post-restriction |
15.32 |
1 |
0 |
0 |
0 |
1.00e+00 |
Epha6
|
Food seeking constrained by brief footshock |
12.39 |
2 |
0 |
0 |
-1 |
7.07e-04 |
Dnajc27
Efr3b
|
Run reversals in cocaine runway, males |
39.32 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Latency to leave start box in cocaine runway |
18.78 |
1 |
0 |
0 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Cd content in liver |
239.3 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Co content in liver |
143.3 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
K content in liver |
87.29 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Mn content in liver |
207.1 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Rb content in liver |
31.44 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|
Se content in liver |
30.07 |
2 |
1 |
5.9 |
0 |
1.00e+00 |
Epha6
ENSRNOG00000064438
|
Zn content in liver |
45.96 |
1 |
1 |
5.9 |
0 |
1.00e+00 |
ENSRNOG00000064438
|